固定剂量复合剂治疗肺结核患者依从性调查与分析

目的调查和分析固定剂量复合剂(FDC)治疗肺结核的患者依从性,为FDC在我国推广应用提供参考。方法选择4省17县结防机构登记的966例初治涂阳肺结核患者,随机分为研究组和对照组,使用统一调查问卷,调查患者不同治疗时期依从性。结果在治疗前调查961例患者回答问题,899例(93.5%)自愿接受治疗;研究组选择每日服药比例86.8%,高于对照组的42.1%,组间有显著性差异(P<0.01)。强化期末,261例(28.3%)感到坚持治疗有困难,213例(23.1%)认为医生督导是坚持治疗的原因。疗程末,138例(15.5%)认为坚持治疗的关键是医生。结论采用固定剂量复合剂患者依从性优于对照组,药片数量减少是提高依从性原因之一,应加以推广;随疗程进展,医生督导作用下降,应加强对患者强化期的管理和督导。

Survey and analysis on the compliance of fixed-dose combination on TB treatment

Objective To survey and analyse the treatment compliance of fixed-dose combination(FDC),so as to provide evidences for expending use FDC nationwide. Methods Nine hundred and sixty-six primary smear positive pulmonary tuberculosis cases registered in 17 counties TB institutions from 4 provinces were randomly divided into experiment and control groups.Compared compliance difference with uniform questionnaires,and analysed compliance changes with time throughout the treatment. Results Nine hundred and sixty-one cases were surveyed at the beginning,899(93.5%)preferred receiving treatment.There was significant difference on the percentage who prefer had drugs per day between experiment(86.8%)and control group(42.1%)(P<0.01).At the end of intensive phase,261(28.3%)cases perceived difficulty with the treatment;213(23.1%)cases thought that were the doctors who lead to the insist of treatment.At the end of treatment,only 138 cases(15.5%)thought that were the doctors who lead to the insist of treatment. Conclusion The compliance of FDC was better than contro1 group.It might increase the compliance when decreasing the number of tablets and should expend used on TB control.The effect of TB doctors decreased through the treatment.More intention should be paid in intense phase.